Cargando…

Towards a Diagnosis of Cardiac Amyloidosis: Single Center Experience with (99m) Technetium Pyrophosphate Planar Imaging and Opportunities for Standardization of Diagnostic Workflow †

Background and Objectives: Cardiac amyloidosis is a disorder caused by amyloid fibril deposition in the extracellular space of the heart. Almost all forms of clinical cardiac amyloidosis are transthyretin amyloidosis (ATTR) or light chain amyloidosis. (99m) technetium pyrophosphate ((99m)Tc PYP scan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saleem, Mariam, Sadat, Besher, Van Harn, Meredith, Ananthasubramaniam, Karthikeyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959230/ https://www.ncbi.nlm.nih.gov/pubmed/36837580 http://dx.doi.org/10.3390/medicina59020378

Ejemplares similares

Extracardiac Accumulation of Technetium-99m-Pyrophosphate in Transthyretin Cardiac Amyloidosis
por: Takahashi, Koji, et al.
Publicado: (2021)

Technetium-99m pyrophosphate cardiac SPECT in endomyocardial biopsy negative cardiac amyloidosis
por: Krupa, Martin, et al.
Publicado: (2018)

Grade 3 myocardial uptake in (99m)technetium-pyrophosphate scintigraphy in light chain cardiac amyloidosis
por: Okada, Atsushi, et al.
Publicado: (2021)

Conversion of (99m)technetium-pyrophosphate scintigraphy in a patient with hereditary ATTR amyloidosis: importance of repeat scanning
por: Hussain, Muzna, et al.
Publicado: (2020)

False positive technetium-99m pyrophosphate scintigraphy in a patient with cardiac amyloidosis light chain: Case report
por: Zeng, Yu, et al.
Publicado: (2021)

(99m)Technetium‐pyrophosphate bone scan: A potential biomarker for the burden of transthyretin amyloidosis in skeletal muscle: A preliminary study
por: Wlodarski, Richard, et al.
Publicado: (2022)

(99m)Technetium‐pyrophosphate scintigraphy: a practical guide for early diagnosis of transthyretin amyloid cardiomyopathy
por: Tahara, Nobuhiro, et al.
Publicado: (2021)

Wild type cardiac amyloidosis: is it time to order a nuclear technetium pyrophosphate SPECT imaging study?
por: Shen, Christine P., et al.
Publicado: (2022)

Comparison of 1-h with 3-h planar (99m)Tc-pyrophosphate scintigraphy in patients with suspected transthyretin cardiac amyloidosis using SPECT as a reference standard
por: Saitou, Toshinori, et al.
Publicado: (2022)

Pitfalls of the Semi-Quantitative Analyzing (99m)Tc-Pyrophosphate Planar Images for Diagnosing Transthyretin Cardiac Amyloidosis: A Possible Solution
por: Zhu, Yuankai, et al.
Publicado: (2022)

Assessment of cardiac amyloidosis with (99m)Tc-pyrophosphate (PYP) quantitative SPECT
por: Ren, Chao, et al.
Publicado: (2021)

Technetium-99m Radiopharmaceuticals for Ideal Myocardial Perfusion Imaging: Lost and Found Opportunities
por: Boschi, Alessandra, et al.
Publicado: (2022)

Diagnosis of bone infection by complementary role of technetium-99m MDP and technetium-99m hexamethylpropylene-amineoxime-leukocytes
por: Al-Zahrani, Abdullah, et al.
Publicado: (2012)

Utility of (99 m)Tc-Pyrophosphate Scintigraphy in Diagnosing Transthyretin Cardiac Amyloidosis in Real-World Practice
por: Tsutsui, Yoshitomo, et al.
Publicado: (2019)

Iatrogenic intramuscular hematoma of the oblique muscles as a complication of technetium-99m-labeled pyrophosphate imaging-based computed tomography-guided core-needle biopsy in a patient with wild-type transthyretin cardiac amyloidosis
por: Takahashi, Koji, et al.
Publicado: (2023)

CORRIGENDUM: Utility of (99 m)Tc-Pyrophosphate Scintigraphy in Diagnosing Transthyretin Cardiac Amyloidosis in Real-World Practice
por: Tsutsui, Yoshitomo, et al.
Publicado: (2019)

Technetium-99m production issues in the United Kingdom
por: Green, Christopher H.
Publicado: (2012)

(99m)Technetium Sestamibi-(123)Iodine Scintigraphy Is More Accurate Than (99m)Technetium Sestamibi Alone before Surgery for Primary Hyperparathyroidism
por: Ryhänen, Eeva M., et al.
Publicado: (2015)

Hybridised production of technetium-99m and technetium-101 with fluorine-18 on a low-energy biomedical cyclotron
por: Johnstone, Erik V., et al.
Publicado: (2023)

Options for UK Technetium-99m Production using Accelerators
por: H.L. Owen, et al.
Publicado: (2014)

Recent Levels of Technetium-99 in Seawater at the West Coast of Svalbard
por: Gerland, Sebastian, et al.
Publicado: (2002)

99m-Technetium Sestamibi Uptake in a Gastric Schwannoma
por: Shawgi, Mohamed, et al.
Publicado: (2018)

Innovative Target for Production of Technetium-99m by Biomedical Cyclotron
por: Skliarova, Hanna, et al.
Publicado: (2018)

The purity identification and radiolabeling of α-mangostin with technetium-99m
por: Muchtaridi, Muchtaridi, et al.
Publicado: (2020)

Usefulness of quantitative (99m)Tc-pyrophosphate SPECT/CT for predicting the prognosis of patients with wild-type transthyretin cardiac amyloidosis
por: Ogasawara, Kouji, et al.
Publicado: (2022)

Volumetric evaluation of (99m)Tc-pyrophosphate SPECT/CT for transthyretin cardiac amyloidosis: Methodology and correlation with cardiac functional parameters
por: Watanabe, Satoru, et al.
Publicado: (2021)

Poor renal uptake of technetium-99m-DMSA and technetium-99m-MDP in a patient with Fanconi syndrome and near normal glomerular filtration rate.
por: Kim, S. E., et al.
Publicado: (1994)

Radiopharmaceutical supply disruptions and the use of (99m)Tc-hydroxymethylene diphosphonate as an alternative to (99m)Tc-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis: An ASNC Information Statement
por: Miller, Edward J., et al.
Publicado: (2022)

Imaging in situ breast carcinoma (with or without an invasive component) with technetium-99m pentavalent dimercaptosuccinic acid and technetium-99m 2-methoxy isobutyl isonitrile scintimammography
por: Papantoniou, Vassilios, et al.
Publicado: (2005)

Randomized comparison between indocyanine green fluorescence plus (99m)technetium and (99m)technetium alone methods for sentinel lymph node biopsy in breast cancer
por: Vermersch, Charlotte, et al.
Publicado: (2019)

Microcalcification and (99m)Tc-Pyrophosphate Uptake without Increased Bone Metabolism in Cardiac Tissue from Patients with Transthyretin Cardiac Amyloidosis
por: Mori, Atsushi, et al.
Publicado: (2023)

Imaging of Primitive Neuroectodermal Tumor (PNET) by Technetium-99m Tetrofosmin
por: Karanikas, Georgios, et al.
Publicado: (2001)

Non-invasive monitoring of photodynamic therapy with 99technetium HMPAO scintigraphy.
por: Moore, R. B., et al.
Publicado: (1992)

Labeling of Tannic Acid with Technetium-99m for Diagnosis of Stomach Ulcer
por: Ibrahim, I. T., et al.
Publicado: (2011)

‘Hockey stick’ sign on 99m Technetium pertechnetate thyroid scan
por: Damle, Nishikant A., et al.
Publicado: (2012)

99m-Technetium binding site in bone marrow mononuclear cells
por: Suhett, Grazielle Dias, et al.
Publicado: (2015)

Characterization, optimization, and in vitro evaluation of Technetium-99m-labeled niosomes
por: De Silva, Leanne, et al.
Publicado: (2019)

The role of Technetium-99m-Ethambutol scintigraphy in the management of spinal tuberculosis
por: Diah, Lisa Herawati, et al.
Publicado: (2019)

Data on biodistribution and dose calculation of (99m)Technetium -Dimercaptosuccinic acid in pediatric patients using a hybrid planar/single emission computed tomography method
por: Bagheri, Mahmoud, et al.
Publicado: (2020)

Myocardial clearance of technetium-99m-teboroxime in reperfused injured canine myocardium
por: Okada, David R, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_5jaepm03giaa59r52gkuuqjaag